Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 26
  • 1
  • 2
  • »
Teri Bedard, RT(R)(T), CPC, shares her highlights of the calendar year 2023 MPFS proposed rule and its potential impact on oncology/hematology.
ACCC Director Cancer Care Delivery and Health Policy Matt Devino, MPH, lays out the four key differences between the OCM and EOM that interested applicants need to consider.
This week, Congress passed a $1.5 trillion omnibus spending package for fiscal year 2022 with broad bipartisan support. Included in the domestic appropriations are several key healthcare provisions of interest to ACCC and the cancer care community.
The Centers for Medicare & Medicaid Services and the American Medical Association's (AMA's) finalized coding updates for calendar year 2022.
If enacted, patients with cancer across the country will benefit from increased access and new fiscal protections, including universal paid family leave.
The Medicare Physician Fee Schedule (MPFS) for calendar year 2022.
By Christian G. Downs, MHA, JD On Oct. 5, ACCC provided comments to the Centers for Medicare & Medicaid Services (CMS) on the agency’s proposed CY 2021 Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS) rules. CMS is expected to release the final CY 2020 Medicare payment rules in early December. Below are highlights from ACCC’s comment letters. Specific to the proposed …
On Aug. 4, the Centers for Medicare & Medicaid Services (CMS) released its 2021 Hospital Outpatient Prospective Payment System (OPPS) and Medicare Physician Fee Schedule (PFS) proposed rules.
“In this town, we’ve seen healthcare become a political lightning rod,” U.S. Senator Debbie Stabenow (D-MI) told attendees on March 5 at the ACCC 46th Annual Meeting & Cancer Center Business Summit (AMCCBS) in Washington, D.C. As our nation grapples with unprecedented challenges—both individually and collectively—posed by the world-wide novel COVID-19 outbreak, it seems as though lightning has …
In this election year, U.S. healthcare policy is center stage. ACCC is monitoring proposed rules and policy changes to gauge their impact on cancer care access and delivery. ACCC Responds to CMMI on Oncology Care First Model ACCC provided comments to the Center for Medicare and Medicaid Innovation’s (CMMI's) request for information on its concept for the Oncology Care First (OCF) Model. While applauding …
In this election year, U.S. healthcare policy is center stage. ACCC is monitoring proposed rules and policy changes to gauge their impact on cancer care access and delivery. Recent policy actions include the Centers for Medicare & Medicaid Services (CMS) release on Feb. 5 of CY 2021/2022 Medicare Advantage and Part D Proposed Rule that would: Require Part D plans to offer real-time drug price …
The Centers for Medicare and Medicaid Services (CMS) released the final Medicare payment rules for calendar year (CY) 2020 in tandem this year on Nov. 1, 2019.
Friday, Nov. 1 was a busy day for the Centers for Medicare & Medicaid Services (CMS) and its Center for the Medicare and Medicaid Innovation (CMMI). CMS released the final calendar year (CY) 2020 Hospital Outpatient Prospective System and Physician Fee Schedule final rules. Later that afternoon, CMMI posted an “informal” Request for Information on a proposal for the next iteration of an …
On Sept. 27, ACCC provided comments to the Centers for Medicare & Medicaid Services (CMS) on the agency’s proposed CY 2020 Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS) rules.
Calendar year (CY) 2020 begins the transition in the Medicare physician fee schedule (PFS) payment system away from fee-for-service reimbursement, which is affected by the changing conversion factor, to a payment system that is set with potential changes related to budget neutrality.
Drug pricing reform and a thorough analysis of healthcare spending have been the focus of healthcare leadership across the country since early 2018.
The future of healthcare is at a crossroads. In the past year, the Trump Administration and Congress have made several proposals to address the rising costs of healthcare and drugs­, which have the potential to dramatically affect the landscape of cancer care. Now more than ever, the voices of professionals on the front lines of cancer care are crucial to shaping the direction of future …
In September 2018, the Association of Community Cancer Centers (ACCC) submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to both the 2019 Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) proposed rules. The arrival of autumn signals seasonal changes, but one constant is the policy implications of the proposed Medicare payment rules …
Effective Oct. 1, 2018, the Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention will add 279 new codes, revise 143 existing codes, and deactivate 51 codes in the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) classification.
Although the Trump administration has maintained a steady drumbeat on pharmaceutical pricing in recent months, promising lower costs for patients and less spending for the government, it wasn’t until late summer that we started to see what this White House had in mind.
    Displaying results 1 - 20 of 26
  • 1
  • 2
  • »